Paget's disease of the tibia

Journal of the Formosan Medical Association

Volumn 98, Issue 6, 1999, Pages 444-447

  Wang, Chung Li ^a   Wu, Chen Tu ^a   Chien, Chun Ru ^a   Hang, Yi Hsiong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Alkaline phosphatase; Bone; Calcium; Epidemiology; Paget's disease

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; SODIUM CHLODRONATE; UNCLASSIFIED DRUG;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; ORAL DRUG ADMINISTRATION; PAGET BONE DISEASE; TIBIA; TREATMENT OUTCOME;

AGED; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; OSTEITIS DEFORMANS; TAIWAN; TIBIA;

EID: 0032791510     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Delmas PD, Meunier PJ: The management of Paget's disease of bone. N Engl J Med 1997;336:558-66.
2. Siris ES: Paget's disease of bone. In: Favus MJ, ed. Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. 2nd ed. New York: Raven Press, 1993:375-84.
3. Merkow RL, Lane JM: Paget's disease of bone. Orthop Clin North Am 1990;21:171-89.
4. Sirikulchayanonta V, Naovaratanophas P, Jesdapatarakul S: Paget's disease of bone - clinicopathology study of the first case report in Thailand. J Med Assoc Thai 1992;75 (suppl):136-9.
5. Yip KMH, Lee YL, Kumta SM, et al: The second case of Paget's disease (Osteitis deformans) in a Chinese lady. Singapore Med J 1996;37:665-7.
6. Barker DJP: The epidemiology of Paget's disease of bone. Br Med Bull 1984;40:396-400.
7. Mirra JM: Paget's disease. In: Mirra JM, ed. Bone Tumors - Clinical, Radiologic and Pathologic Correlations. Philadelphia: Lea & Febiger, 1989:893-940.
8. Dokoh S, Morikawa S, Shimbo S, et al: Fifteen cases of Paget's disease of bone - roentgenographic, scintigraphic and histological findings. Nippon Igaku Hoshasen Gakkai Zasshi 1985;45:1206-19. [In Japanese].
9. Meunier PJ, Coindre JM, Edouard CM, et al: Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthritis Rheum 1980;23:1095-103.
10. Hosking D, Meunier PJ, Ringe JD, et al: Paget's disease of bone: diagnosis and management. BMJ 1996;312:491-4.
11. Alvarez L, Guanabens N, Peris P, et al: Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. J Bone Miner Res 1995; 10:458-65.
12. Uebelhart D, Gineyts E, Chapuy MC, et al: Urinary excretion of pyridinium cross-links: a new marker of bone resorption in metabolic bone disease. Bone 1990;8:87-96.
13. Compston JE: The therapeutic use of bisphosphonates. BMJ 1994;309:711-5.
14. Patel S, Lyons AR, Hosking DJ: Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Drugs 1993;46:594-617.
15. Fleisch H, Russell RG, Francis MD: Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture in vivo. Science 1969;165:1262-4.
16. Zimolo Z, Wesolowski G, Rodan GA: Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin. J Clin Invest 1995;96: 2277-83.
17. Fleisch H: Bisphosphonates: mechanisms of action and clinical use. In: Mundy GR, Martin TJ, eds. Handbook of Experimental Pharmacology. Physiology and Pharmacology of Bone. Berlin: Springer-Verlag, 1993:107;377-418.